Literature DB >> 21210762

Viral gastroenteritis in adults.

Alexander J Eckardt1, Daniel C Baumgart.   

Abstract

Viral gastroenteritis presents a major public health concern worldwide. It is mostly a disease of young children. However, acquired immunity may wane and symptomatic infection can also occur in adults. Furthermore, asymptomatic adults may promote the spread of infections by shedding virus in their stools. This review covers the four most common causes of adult viral gastroenteritis, Calicivirirdae (predominantly noroviruses), astroviruses, enteric adenoviruses and rotaviruses focussing on their epidemiologic, structural, pathogenic and clinical aspects. In addition, current and future prevention and treatment options are discussed, including recent patents. While specific inhibitors of viral replication are currently not available, we summarized non-specific anti-viral agents and potential targets for the most important adult pathogen, Norovirus. Special emphasis is put on current and future vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21210762     DOI: 10.2174/157489111794407877

Source DB:  PubMed          Journal:  Recent Pat Antiinfect Drug Discov        ISSN: 1574-891X


  20 in total

1.  Prevalence of rotavirus, norovirus and enterovirus in diarrheal diseases in Himachal Pradesh, India.

Authors:  Swapnil Jain; Nutan Thakur; Neelam Grover; Jitendraa Vashistt; Harish Changotra
Journal:  Virusdisease       Date:  2016-02-03

2.  Structural and inhibitor studies of norovirus 3C-like proteases.

Authors:  Daisuke Takahashi; Yunjeong Kim; Scott Lovell; Om Prakash; William C Groutas; Kyeong-Ok Chang
Journal:  Virus Res       Date:  2013-09-17       Impact factor: 3.303

3.  Potent inhibition of norovirus by dipeptidyl α-hydroxyphosphonate transition state mimics.

Authors:  Sivakoteswara Rao Mandadapu; Mallikarjuna Reddy Gunnam; Anushka C Galasiti Kankanamalage; Roxanne Adeline Z Uy; Kevin R Alliston; Gerald H Lushington; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2013-08-22       Impact factor: 2.823

4.  Potent inhibition of norovirus 3CL protease by peptidyl α-ketoamides and α-ketoheterocycles.

Authors:  Sivakoteswara Rao Mandadapu; Pathum M Weerawarna; Mallikarjuna Reddy Gunnam; Kevin R Alliston; Gerald H Lushington; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2012-05-26       Impact factor: 2.823

5.  Potent norovirus inhibitors based on the acyclic sulfamide scaffold.

Authors:  Dengfeng Dou; Kok-Chuan Tiew; Sivakoteswara Rao Mandadapu; Mallikarjuna Reddy Gunnam; Kevin R Alliston; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem       Date:  2012-02-02       Impact factor: 3.641

6.  Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors.

Authors:  Sivakoteswara Rao Mandadapu; Mallikarjuna Reddy Gunnam; Kok-Chuan Tiew; Roxanne Adeline Z Uy; Allan M Prior; Kevin R Alliston; Duy H Hua; Yunjeong Kim; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2012-11-21       Impact factor: 2.823

7.  Epidemiological studies on gastroenteritis in children in the Bannu district, Khyber Pakhtunkhwa, Pakistan.

Authors:  Muhammad Ashraf Khan
Journal:  Z Gesundh Wiss       Date:  2021-05-21

Review 8.  Gut inflammation and immunity: what is the role of the human gut virome?

Authors:  Alfredo Focà; Maria Carla Liberto; Angela Quirino; Nadia Marascio; Emilia Zicca; Grazia Pavia
Journal:  Mediators Inflamm       Date:  2015-04-07       Impact factor: 4.711

9.  Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus.

Authors:  Sivakoteswara Rao Mandadapu; Pathum M Weerawarna; Allan M Prior; Roxanne Adeline Z Uy; Sridhar Aravapalli; Kevin R Alliston; Gerald H Lushington; Yunjeong Kim; Duy H Hua; Kyeong-Ok Chang; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2013-05-16       Impact factor: 2.823

10.  High prevalence and diversity of species D adenoviruses (HAdV-D) in human populations of four Sub-Saharan countries.

Authors:  Maude Pauly; Eileen Hoppe; Lawrence Mugisha; Klara Petrzelkova; Chantal Akoua-Koffi; Emmanuel Couacy-Hymann; Augustin Etile Anoh; Arsène Mossoun; Grit Schubert; Lidewij Wiersma; Sabwe Pascale; Jean-Jacques Muyembe; Stomy Karhemere; Sabrina Weiss; Siv Aina Leendertz; Sébastien Calvignac-Spencer; Fabian H Leendertz; Bernhard Ehlers
Journal:  Virol J       Date:  2014-02-11       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.